Robert J. Terifay, SVP Commercial at REGENERON PHARMACEUTICALS INC (REGN), sold 27,795 shares at $331.66 ($9.1M) on 2014-02-18, disclosed to the SEC on 2014-02-19.
Open-market sale of $9.1M REGN by SVP Commercial. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $323.30 | 1,826 | $590K | 6.5% |
| 2 | $323.30 | 13,104 | $4.2M | 46.5% |
| 3 | $331.66 | 3,497 | $1.2M | 12.7% |
| 4 | $332.75 | 6,603 | $2.2M | 24.1% |
| 5 | $333.79 | 2,765 | $923K | 10.1% |
| Total | $327.64 avg | 27,795 |
| $9.1M |
| 100% |
| Filing → |
| REGN | SELL | 2015-03-18 | $5.0M | — | Filing → |
| REGN | SELL | 2015-02-25 | $4.7M | — | Filing → |
| REGN | SELL | 2014-11-19 | $9.1M | — | Filing → |